STOCK TITAN

TRANSUITE ORG (TRSO) Stock Price, News & Analysis

TRSO OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
87 113 sessions, September 4, 2025 to September 4, 2026
Largest daily move
+295.8% close of November 5, 2025
1-year change
-95.4% closing prices, September 4, 2025 to September 4, 2026

Company Description

TRANSUITE ORG INC (TRSO), also referenced in filings as Transuite.Org Inc., is a Nevada corporation that has been reshaping its business through acquisitions and technology-focused initiatives. According to its SEC disclosures, the company has pursued transactions in areas such as intelligent electric bicycle (E-Bike) charging and management solutions, AI-driven wellness technology based on Traditional Chinese Medicine (TCM), and AI-related consulting services.

Corporate background and structure

Transuite.Org Inc. is incorporated in Nevada, with a Commission File Number of 333-255178 and Employer Identification Number 30-1129581, as disclosed in multiple Form 8-K and Form 12b-25 filings. The company’s filings describe a holding structure that includes Goldfinch Group Holdings Ltd., a British Virgin Islands company, and Crestar Holdings Limited, a Hong Kong company that is a wholly owned subsidiary of Goldfinch.

Through this structure, TRSO has used share exchange agreements and stock issuances to acquire interests in operating businesses in technology and digital asset–adjacent fields. The company has also adopted a stock incentive plan to grant equity-based awards to officers, directors, employees, and consultants.

Intelligent E-Bike charging and IoT platform

A key business line described in TRSO’s filings arises from its acquisition of a majority interest in Goldfinch Group Co., Limited (Goldfinch HK). Goldfinch HK owns 100% of Goldfinch-Chong (Fuzhou) Technology Co., Ltd. (Goldfinch-Chong), which is characterized in the company’s 8-K filing as an intelligent E-Bike charging and management solutions provider headquartered in Fuzhou, China.

According to that filing, Goldfinch-Chong operates a platform serving more than 1.6 million active loyal users with approximately 100,000 E-Bike charging terminals. The platform includes integrated management systems that cover customer relationship management, agent network management, intelligent billing and revenue sharing, and various Internet of Things (IoT) applications. These IoT applications include smoke detection, access control, and automotive charging management, indicating a focus on connected infrastructure and operational monitoring.

The same filing notes that Goldfinch-Chong plans to launch an E-Bike charging asset revenue rights on-chain (RWA) initiative, using Web3 technologies to enhance the financial value of charging infrastructure assets. This illustrates TRSO’s exposure, through its subsidiaries, to Web3 and real-world asset tokenization concepts as described in its own disclosures.

AI-driven wellness and Traditional Chinese Medicine (TCM)

Transuite.Org Inc. has also expanded into AI-powered healthcare technology through the acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. (XRS). An 8-K filing describes XRS as an innovative enterprise that combines an AI Social Agent with Traditional Chinese Medicine principles, with a stated vision of building a self-medical platform for AI Traditional Chinese Medicine.

According to the filing, XRS focuses on creating an ecosystem around a “self medical concept,” self-medical methods, and a health supervision system. Its core products are described as an AI Social Agent based on a large TCM knowledge base, a 21-day health supervision system, and a series of approximately 300 TCM health e-books with independent intellectual property certifications. The company’s disclosure also mentions plans for a fully intelligent e-commerce platform and a "Super IP Li Ziyi" AI persona intended to serve users in multiple languages through major social platforms.

In addition to E-Bike infrastructure and AI-driven wellness technology, TRSO’s filings describe activity in broader AI and digital asset–related fields. In its Form 12b-25 notification of late filing, the company references a Letter of Intent and subsequent definitive Share Exchange Agreement to acquire a majority interest in SolanAI Global Limited, described as a Hong Kong–based AI technology company. The same filing notes that this transaction is expected, upon completion and subject to closing conditions, to strengthen the company’s AI research and development capabilities and expand its presence in the Asian market.

The Form 12b-25 also indicates that TRSO generated revenue from an AI-Driven Ecosystem Product Planning consulting service during the period discussed in that filing. This suggests that, in addition to acquisitions, the company has offered consulting services connected to AI-driven ecosystem planning, as described in its own narrative.

TRSO has also entered into Letters of Intent to potentially acquire equity interests in companies such as SYD GOLDX PTY LTD, an Australian licensed digital currency exchange, and Fujian Wochong Intelligent Technology Co., Ltd., a company incorporated in China. The filings emphasize that these LOIs are non-binding and subject to due diligence, board approvals, and definitive agreements, and that there is no assurance that the proposed transactions will be completed.

Equity structure and incentive plans

The company’s 8-K filings describe the use of restricted common stock as consideration in its acquisitions. For example, TRSO agreed to issue five million shares of restricted common stock to acquire a 51% equity interest in Goldfinch HK, and it initially issued ten million restricted shares as consideration for the acquisition of XRS, with potential additional shares based on future valuations.

Another 8-K filing reports that holders of a majority of the company’s voting power approved the adoption of a 2025 Stock Incentive Plan. Under this plan, the Board of Directors may grant incentive stock options, nonqualified stock options, and restricted stock awards to officers, directors, employees, and consultants, with a specified number of common shares reserved for issuance under the plan at the time of approval.

Governance and management developments

Several 8-K filings detail changes in TRSO’s leadership and board composition. These filings describe the appointment of new directors, including independent directors with backgrounds in quantitative trading technology, financial technology, digital assets, corporate advisory, and investment banking services. They also describe changes in principal officers, including transitions in the roles of President and Secretary and the consolidation of roles by the Chief Executive Officer.

The filings emphasize that, in the cases described, the resignations of certain officers were not the result of any disagreement with the company on matters relating to operations, policies, or practices, and that there were no family relationships or related-party transactions requiring disclosure under Regulation S-K for the newly appointed officers and directors.

Regulatory filings and reporting

Transuite.Org Inc. files reports with the U.S. Securities and Exchange Commission under Section 13 or 15(d) of the Securities Exchange Act of 1934. The Form 12b-25 notification indicates that the company has, over the relevant period, filed other required periodic reports and that it sought a short extension to file a Form 10-Q due to delays in assembling required information.

The same filing provides a narrative explanation of anticipated significant changes in results of operations, including revenue from AI-Driven Ecosystem Product Planning consulting services and increased operating expenses related to stock-based compensation, audit fees, accounting fees, and legal fees. While specific figures are included in the filing, investors should refer directly to the company’s SEC reports for detailed financial statements and quantitative data.

Business focus and sector classification

Based on its own disclosures, TRSO’s activities span several technology-oriented areas: intelligent E-Bike charging and IoT platforms, AI-driven wellness technology grounded in Traditional Chinese Medicine, AI technology development, and digital asset–related initiatives. The company’s acquisitions and proposed transactions indicate a focus on AI, Web3, and digital infrastructure applications, though its formal industry and sector classifications are not specified in the provided data.

FAQs about TRANSUITE ORG INC (TRSO)

  • What does Transuite.Org Inc. do?

    According to its SEC filings, Transuite.Org Inc. operates through subsidiaries and acquired entities involved in intelligent E-Bike charging and management solutions, AI-driven wellness technology based on Traditional Chinese Medicine, AI technology development, and AI-Driven Ecosystem Product Planning consulting services.

  • How is TRSO involved in E-Bike charging and IoT?

    TRSO, through its ownership of Goldfinch Group Holdings Ltd. and its subsidiary Crestar, acquired a 51% equity interest in Goldfinch Group Co., Limited. Goldfinch HK owns Goldfinch-Chong, which is described as an intelligent E-Bike charging and management solutions provider operating a platform with E-Bike charging terminals and integrated IoT-based management systems.

  • What is Goldfinch-Chong’s business as described by TRSO?

    Goldfinch-Chong is described in TRSO’s 8-K filing as a provider of intelligent E-Bike charging and management solutions headquartered in Fuzhou, China. It operates a platform that includes customer relationship management, agent network management, intelligent billing and revenue sharing, and IoT applications such as smoke detection, access control, and automotive charging management.

  • How is TRSO involved in AI-driven wellness and Traditional Chinese Medicine?

    TRSO acquired 100% of the equity of Xirangsheng (Shenzhen) Health Technology Co., Ltd. (XRS) through its subsidiary Crestar. XRS is described as combining an AI Social Agent with Traditional Chinese Medicine principles and offering products such as an AI Social Agent based on a large TCM knowledge base, a 21-day health supervision system, and a series of TCM health e-books.

  • What AI and digital asset–related initiatives does TRSO describe?

    In its Form 12b-25 and 8-K filings, TRSO references a proposed acquisition of a majority interest in SolanAI Global Limited, a Hong Kong-based AI technology company, and Letters of Intent to acquire interests in a licensed digital currency exchange and a Chinese technology company. It also notes that Goldfinch-Chong plans an E-Bike charging asset revenue rights on-chain (RWA) initiative using Web3 technologies.

  • How does Transuite.Org Inc. use its stock in acquisitions?

    TRSO’s 8-K filings describe the issuance of restricted shares of common stock as consideration in share exchange agreements. For example, the company agreed to issue restricted shares to acquire a 51% interest in Goldfinch HK and issued restricted shares as initial consideration for the acquisition of XRS, with potential additional shares based on independent valuations.

  • What is the 2025 Stock Incentive Plan mentioned in TRSO’s filings?

    An 8-K filing states that holders of a majority of the company’s voting power approved the adoption of the 2025 Stock Incentive Plan. This plan allows the Board of Directors to grant incentive stock options, nonqualified stock options, and restricted stock awards to officers, directors, employees, and consultants, with a specified number of shares reserved for issuance under the plan.

  • What kinds of revenue does TRSO report in its narrative disclosures?

    In its Form 12b-25, TRSO states that during the periods discussed it generated revenue from its AI-Driven Ecosystem Product Planning consulting service. The filing also discusses changes in operating expenses and net loss, but investors should consult the company’s full financial statements for detailed figures.

  • Is Transuite.Org Inc. focused on any particular geographic markets?

    TRSO’s filings describe operations and counterparties in several locations. Goldfinch-Chong is headquartered in Fuzhou, China, XRS is based in Shenzhen, China, SolanAI Global Limited is described as a Hong Kong-based AI technology company, and one proposed transaction involves an Australian licensed digital currency exchange. The company itself is incorporated in Nevada.

  • How does TRSO describe its reporting status with the SEC?

    In its Form 12b-25, TRSO indicates that it has filed other required periodic reports under Section 13 or 15(d) of the Exchange Act during the preceding 12 months and that it sought a brief extension to file a Form 10-Q due to delays in assembling required information.

Stock Performance

$—
-
-
Last updated:
-95.4%
Performance 1 year
$13.9M

TRANSUITE ORG (TRSO) closed at $0.1799 on September 4, 2026. Over the past 12 months, the price has lost 95.4%.

See what a $1,000 investment in TRSO would be worth today

TRSO Metrics & Rankings

Price returns through September 4, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for TRSO.

SEC Filings

TRANSUITE ORG has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on September 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRSO SEC filings →

Financial Highlights

TRANSUITE ORG generated $118K in revenue in FY2025, retaining a 99.8% gross margin. Diluted earnings per share stood at -$1.52. The company generated -$69K in operating cash flow. With a current ratio of 0.40, short-term liquidity bears monitoring.

$118K
Revenue (FY2025)
-$69K
Operating Cash Flow
$118K
Gross Profit (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in TRANSUITE ORG (TRSO) currently stands at 25 shares. Since September 2025, short interest has decreased by 99.0%.

Days to Cover History

Last 12 Months

Days to cover for TRANSUITE ORG (TRSO) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

TRSO Company Profile & Sector Positioning

TRANSUITE ORG (TRSO) operates in the Software - Application industry within the broader Technology sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of TRANSUITE ORG (TRSO)?

The current stock price of TRANSUITE ORG (TRSO) is $0.1799 as of September 4, 2026.

What is the market cap of TRANSUITE ORG (TRSO)?

The market cap of TRANSUITE ORG (TRSO) is approximately $13.9M. Learn more about what market capitalization means .

What is the revenue of TRANSUITE ORG (TRSO) stock?

The FY2025 revenue of TRANSUITE ORG (TRSO) is $118K, from its most recent completed fiscal year.

What is the earnings per share (EPS) of TRANSUITE ORG (TRSO)?

The diluted earnings per share (EPS) of TRANSUITE ORG (TRSO) is -$1.52 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of TRANSUITE ORG (TRSO)?

The operating cash flow of TRANSUITE ORG (TRSO) is -$69K. Learn about cash flow.

What is the gross margin of TRANSUITE ORG (TRSO)?

The gross profit margin of TRANSUITE ORG (TRSO) is 99.8%. Learn about gross margins.

What is the current ratio of TRANSUITE ORG (TRSO)?

The current ratio of TRANSUITE ORG (TRSO) is 0.40, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of TRANSUITE ORG (TRSO)?

The gross profit of TRANSUITE ORG (TRSO) is $118K for FY2025, its most recent completed fiscal year.